Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB04958 | Epratuzumab | 1 / 2 | Unknown Status | 1 |
| DB05656 | Veltuzumab | 1 / 2 | Unknown Status | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB04958 | Epratuzumab | 1 / 2 | Unknown Status | 1 |
| DB05656 | Veltuzumab | 1 / 2 | Unknown Status | 1 |